Rotterdam, Netherlands

Ronald Van Der Geest

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ronald Van Der Geest: Innovator in Medical Treatments

Introduction

Ronald Van Der Geest is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of medical treatments, particularly in addressing complex health issues. With a total of 3 patents to his name, his work focuses on innovative solutions for serious medical conditions.

Latest Patents

One of his latest patents is titled "Methods for the treatment of polycystic kidney disease." This invention discloses compounds that may be useful in the prophylaxis and treatment of polycystic kidney disease (PKD). The patent outlines methods for producing these compounds and their pharmaceutical compositions. Another significant patent is "Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders." This invention relates to the use of a liquid aqueous solution of edaravone for treating various neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. The treatment involves daily oral administration of the solution to provide a specific dosage over a set period.

Career Highlights

Throughout his career, Ronald has worked with several companies, including Treeway Tw001 B.V. and Galapagos NV. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.

Collaborations

Ronald has collaborated with notable professionals in his field, including Sytske Hyke Moolenaar and Ana Fernandez Casares. These collaborations have further enhanced his research and development efforts.

Conclusion

Ronald Van Der Geest is a distinguished inventor whose work in medical treatments has the potential to improve the lives of many patients. His innovative patents reflect his commitment to addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…